No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Nanollose Limited is an Australian biomaterials enterprise dedicated to the research, development, and commercialization of microbial nanocellulose technology. Its product line features Nullarbor Fibre, an innovative lyocell fibre produced without relying on trees, and Jelli Grow, an eco-friendly substitute for seed germination and cultivating plants. These materials find applications across various sectors, including textiles, nonwoven fabrics, and other industries. Established in 2014, the company's headquarters are situated in Nedlands, Australia.
www.nanollose.comNo one on the platform currently holds NC6.AX.
No tracked institution reports a position in NC6.AX as of their last filing.
No one on the platform has traded NC6.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NC6.AXNanollose Limited | $0.07 | -6.25% | $31M | — |
| AGH.AXAlthea Group Holdings Limited | $0.02 | -4.76% | $17M | — |
| AVE.AXAvecho Biotechnology Limited | $0.02 | -4.76% | $77M | — |
| BTC.AXBTC Health Limited | $0.06 | +0.00% | $21M | — |
| FRE.AXFirebrick Pharma Limited | $0.03 | +0.00% | $7M | — |
| IMC.AXImmuron Limited | $0.04 | -13.73% | $11M | — |
| IME.AXImExHS Limited | $0.33 | +0.00% | $18M | — |
Source: Financial Modeling Prep · peers by sector/industry